196 related articles for article (PubMed ID: 2796871)
1. Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Bergeron M; Layrargues GP; Butterworth RF
Metab Brain Dis; 1989 Sep; 4(3):169-76. PubMed ID: 2796871
[TBL] [Abstract][Full Text] [Related]
2. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Bergeron M; Reader TA; Layrargues GP; Butterworth RF
Neurochem Res; 1989 Sep; 14(9):853-9. PubMed ID: 2480534
[TBL] [Abstract][Full Text] [Related]
3. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Lavoie J; Giguère JF; Layrargues GP; Butterworth RF
J Neurochem; 1987 Sep; 49(3):692-7. PubMed ID: 2886551
[TBL] [Abstract][Full Text] [Related]
4. [Aromatic and branched chain amino acids after porto-caval anastomosis: plasma and brain regional levels in the rat (author's transl)].
Dussini N; Zanchin G; Rigotti P; Chiandetti L; Vassanelli P; Battistin L
Riv Patol Nerv Ment; 1978; 99(4):235-43. PubMed ID: 752183
[TBL] [Abstract][Full Text] [Related]
5. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
Watanabe A; Takesue A; Higashi T; Nagashima N
Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
[TBL] [Abstract][Full Text] [Related]
6. Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Rao VL; Giguère JF; Layrargues GP; Butterworth RF
Brain Res; 1993 Sep; 621(2):349-52. PubMed ID: 8242348
[TBL] [Abstract][Full Text] [Related]
7. Selective increases of extracellular brain concentrations of aromatic and branched-chain amino acids in relation to deterioration of neurological status in acute (ischemic) liver failure.
Michalak A; Butterworth RF
Metab Brain Dis; 1997 Dec; 12(4):259-69. PubMed ID: 9475499
[TBL] [Abstract][Full Text] [Related]
8. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
Holecek M
Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
[TBL] [Abstract][Full Text] [Related]
9. Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy.
Millikan WJ; Henderson JM; Warren WD; Riepe SP; Kutner MH; Wright-Bacon L; Epstein C; Parks RB
Ann Surg; 1983 Mar; 197(3):294-304. PubMed ID: 6402994
[TBL] [Abstract][Full Text] [Related]
10. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
[TBL] [Abstract][Full Text] [Related]
11. Region-selective decreases in densities of [3H]tryptamine binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Mousseau DD; Layrargues GP; Butterworth RF
J Neurochem; 1994 Feb; 62(2):621-5. PubMed ID: 8294925
[TBL] [Abstract][Full Text] [Related]
12. Amino acid disturbances in experimental hepatic coma rats.
Shi ZQ; Chang TM
Int J Artif Organs; 1984 Jul; 7(4):197-202. PubMed ID: 6490191
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
14. Branched chain amino acid therapy in liver disease.
Maddrey WC
J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
[TBL] [Abstract][Full Text] [Related]
15. An approach to nutritional therapy of hepatic encephalopathy by normalization of deranged amino acid patterns in serum.
Watanabe A; Higashi T; Nagashima H
Acta Med Okayama; 1978 Dec; 32(6):427-40. PubMed ID: 154828
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients.
McGhee A; Henderson JM; Millikan WJ; Bleier JC; Vogel R; Kassouny M; Rudman D
Ann Surg; 1983 Mar; 197(3):288-93. PubMed ID: 6830337
[TBL] [Abstract][Full Text] [Related]
17. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
Ferenci P; Funovics J; Wewalka F
Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
20. Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Butterworth RF; Lavoie J; Giguère JF; Pomier-Layrargues G
Hepatology; 1988; 8(5):1084-8. PubMed ID: 2843451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]